亚硝胺
风险分析(工程)
更安全的
过程(计算)
生化工程
钥匙(锁)
计算机科学
化学
风险评估
业务
风险管理
过程管理
管理科学
样品(材料)
多样性(控制论)
消费者安全
公共卫生政策
公共卫生
作者
Ganesh D. Rahangdale,Krishna Radheshyam Gupta,Milind Janrao Umekar
标识
DOI:10.2174/0115734110388388250925134154
摘要
The emergence of nitrosamine impurities in therapeutic products has created significant attention due to their genetically toxic and carcinogenic potential. This review emphasizes the crucial role of pharmaceutical analysis in identifying and quantifying nitrosamines, thereby ensuring medication safety and compliance with legal regulations. Nitrosamines can originate from various sources, including raw materials, solvents, and nitrosating agents, necessitating comprehensive risk evaluation and management. Key types of nitrosamines, their Acceptable Intake (AI) limits, and their impact on public health are discussed. High-Performance Liquid Chromatography (HPLC), Gas Chromatography- Mass Spectrometry (GC-MS), and Liquid Chromatography-Mass Spectrometry (LC-MS) are examples of sophisticated analytical methods that are now essential for detecting and measuring nitrosamines with great accuracy and sensitivity. New methods and innovative sample preparation methods are also explored for their potential to enhance analytical performance. Unlike previous reviews that often focus separately on toxicological, regulatory, or analytical aspects, this study presents a comprehensive, integrative approach that bridges recent regulatory developments with stateof- the-art detection technologies. Special emphasis is given to emerging trends in analytical innovation and proactive risk mitigation strategies, which are less explored in current literature. Regulatory agencies have outlined a three-step process to control nitrosamine contamination, which includes source identification, risk evaluation, and mitigation. This review highlights reformulation, process optimization, and alternative materials as key strategies. It emphasizes the integration of regulatory guidance and scientific innovation to enhance analytical methods, reduce impurities, and ensure safer pharmaceuticals, reinforcing public trust and commitment to health.
科研通智能强力驱动
Strongly Powered by AbleSci AI